| 摘要 |
The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating prediabetes, diabetes, insulin resistance or metabolic syndrome. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of at least vitamin D, gamma tocopherol, niacin, folate, chromium, zinc, magnesium, potassium, bilberry, resveratrol, holy basil and berberine, in pre-determined amounts. The composition can further comprise a palliative agent, and can be provided in the form of a capsule, powder, liquid or tablet. |
| 主权项 |
1. A composition for treating diabetes-related disorders, comprising:
between about 1,000 and about 10,000 IU of vitamin D3; between about 20 to about 200 mg of vitamin E; between about 5 and about 500 mg of niacin; between about 25 mcg and about 1,000 mcg of folate; between about 50 and about 500 mg of magnesium; between about 1 and about 40 mg of zinc; between about 100 and about 500 mcg of chromium; between about 30 and about 300 mg of potassium; between about 50 and about 1,000 mg of berberine; between about 10 and about 1,000 mg of Holy basil leaf; between about 25 and about 800 mg of resveratrol; and between about 10 and about 400 mg of bilberry. |
